Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats

Human and Experimental Toxicology

Volumn 30, Issue 11, 2011, Pages 1840-1848

  Ekor, Martins ^a,b   Odewabi, Adesina O ^b   Kale, Oluwafemi E ^b   Oritogun, Kolawole S ^b   Adesanoye, Omolola A ^c   Bamidele, Titilayo O ^d  

^a REDEEMER S UNIVERSITY   (Nigeria)

^b OLABISI ONABANJO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d NASARAWA STATE UNIVERSITY   (Nigeria)

Author keywords

carbon tetrachloride; hepatotoxicity; RAS inhibitors; renin angiotensin system

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHOLESTEROL; ENALAPRIL; GLUTATHIONE; LOSARTAN; MALONALDEHYDE; PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY LIVER; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; LIVER WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; DRUG-INDUCED LIVER INJURY; ENALAPRIL; GLUTATHIONE; LIVER; LOSARTAN; MALONDIALDEHYDE; ORGAN SIZE; RATS; RATS, WISTAR;

RATTUS;

EID: 80055049312     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111401051     Document Type: Article

References (33)

1. Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005 ; 54: 1790-1796
2. Herath CB, Warner FJ, Lubel JS, et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol. 2007 ; 47: 387-395
3. Warner FJ, Lubel JS, McCaughan GW, Angus PW. Liver fibrosis: a balance of ACEs?. Clin Sci (Lond.). 2007 ; 113: 109-118
4. Pereira RM, Dos Santos RA, Teixeira MM, et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). J Hepatol. 2007 ; 46 (4). 674-681
5. Lubel JS, Angus PW. Modern management of portal hypertension. Intern Med J. 2005 ; 35: 45-49
6. Lubel JS, Herath CB, Burrell LM, Angus PW. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol. 2008 ; 23 (9). 1327-1338
7. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005 ; 115: 209-218
8. Uhal BD, Gidea C, Bargout R, et al. Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. Am J Physiol. 1998 ; 275 (5 Pt 1). L1013 - L1017
9. Hebert LA, Falkenhain ME, Nahman NS, Cosio FG, O'Dorisio TM. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol. 1999 ; 19: 1-6
10. Kodavanti PR, Joshi UM, Young RA, Meydrech EF, Mehendale HM. Protection of hepatotoxic and lethal effects of CCl4 by partial hepatectomy. Toxicol Pathol. 1989 ; 17: 494-505
11. Slater T.F Biological reactive intermediates, chemical mechanisms as biological effects. Synder R Parke DV Kocsis J Jollow DJ Gibson GG, ed. New York: Plenum publishing Co. ; 1982: 575-609.
12. Bruckner JV, Mackenzie W.F, Muralidhara S, Luthra R, Kyle GM, Acosta D. Oral toxicity of carbon tetrachloide: acute, subacute, and subchronic studies in rats. Fund Appl Toxicol. 1986 ; 6: 16-34
13. Reitman S, Frankel SA. Colorimetric method for the determination of serum glutamate-oxaloacetate and pyruvate transaminases. Am J Clin Pathol. 1957 ; 28: 56-63
14. Roy AV. Rapid method for determining alkaline phosphatase activity in serum with thymolphthalein monophosphate. Clin Chem. 1970 ; 16 (5). 431-436
15. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the Biuret reaction. J Biol Chem. 1949 ; 751: 177
16. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromocresol green reaction. Clin Chem. 1971 ; 22: 616-622
17. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963 ; 61: 882-888
18. Varshney R, Kale RK. Effect of calmodulin antagonist on radiation induced lipid peroxidation in microsomes. Int J Radiat Biol. 1990 ; 58 (5). 733-743
19. Fossati P, Prencipe L., Bert G. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in indirect enzymatic assay of uric acid in serum and urine. Clin Chem. 1980 ; 26: 227-231
20. Trinder P. Quantitative determination of triglyceride using GPO-PAP method. Ann Clin Biochem. 1969 ; 6: 24-27
21. Levine G Hillsdale, NJ: Lawrence Erlbaum Associates Inc., Publishers ; 1991: 65-67.
22. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW. Up-regulation of components of the renin angiotensin system in the bile duct-ligated rat liver. Gastroenterology. 2002 ; 123: 1667-1676
23. Hagley MT, Hulisz DT, Burns CM. Hepatotoxicity associated with angiotensin-converting anyzme inhibitors. Ann Pharmacother. 1992 ; 27: 228-231
24. Nygaard B, Strandgaard S. Marked hepatotoxicity associated with losartan treatment. Blood Pressure. 1996 ; 5 (3). 190-191
25. Bosch X. Losartan-induced hepatotoxicity. J Am Med Assoc. 1997 ; 278 (19). 1572
26. Westphal JF, Brogard JM. Drug administration in chronic liver disease. Drug Safety. 1997 ; 17: 47-73
27. Jurima-Romet M, Huang HS. Comparative cytotoxicity of angiotensin-converting enzyme inhibitors in cultured rat hepatocytes. Biochem Pharmacol. 1993 ; 14: 2163-2170
28. Ovali E., Etüner M, Ratüp S, et al. Effects of angiotensin converting enzyme inhibitors in healthy rats and in rats with carbon tetrachloride-induced toxic hepatitis. Turk J Med Sci. 2000 ; 30: 321-325
29. Ibanez P, Solis N, Pizarro M, et al. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2007 ; 22: 846-851
30. Hirose A, Ono M, Saibara T, et al. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology. 2007 ; 45: 1375-1381
31. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans. 2007 ; 35: 1147-1150
32. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol. 2001 ; 54 (3). 176-186
33. Genestra M. Oxylradicals, redox-sensitive signaling cascades and antioxidants. Cell Signal. 2007 ; 19: 1807-1819